Á
L. Chacun-Lefevre et al. / Tetrahedron 56 (2000) 4491±4499
4497
(chromatography eluent: petroleum ether±ethyl acetate
1:1); mp 136±1378C (ethyl acetate±petroleum ether); IR
indole-1,5-dione (14). Yield: 12%; mp 146±1478C (ethyl
acetate±petroleum ether); IR (KBr) n broad 1638 (CO)
1
(KBr) n 1650 (CO), 1632 (CO) cm21
;
1H NMR
cm21; H NMR (250 MHz, CDCl3) d 1.35 (d, 3H, J
(250 MHz, CDCl3) d 2.69±2.74 (m, 2H, CH2), 3.71±3.75
(m, 2H, CH2), 3.84 (s, 3H, CH3), 4.11 (s, 3H, CH3), 4.82 (s,
2H, CH2), 6.90±6.93 (m, 2H, HAr), 7.29±7.45 (m, 6H, HAr);
13C NMR (62.90 MHz, CDCl3) d 33.3 (CH3), 44.1 (CH2),
44.5 (CH2), 50.7 (CH2), 55.8 (CH3), 110.0 (CH), 114.2
(2CH), 115.3 (C), 123.4 (CH), 123.5 (CH), 124.9 (C),
125.4 (CH), 128.8 (C), 129.6 (2CH), 134.5 (C), 138.4 (C),
159.2 (C), 161.3 (CO), 195.4 (CO); Anal. Calcd for
C21H20N2O2: C, 72.40; H, 5.79; N, 8.04. Found: C, 72.06;
H, 5.96; N, 8.20; MS m/z 349 (M11)1.
7.8 Hz, CH3), 2.88±2.95 (m, 1H, CH), 3.36 (s, 3H, CH3),
3.76±3.81 (m, 2H, CH2), 4.10 (s, 3H, CH3), 7.36±7.47 (m,
3H, HAr), 8.42±8.46 (m, 1H, HAr); 13C NMR (62.90 MHz,
CDCl3) d 16.2 (CH3), 34.1 (CH3), 37.9 (CH3), 48.4 (CH),
54.2 (CH2), 111.5 (CH); 116.7 (C), 125.0 (2CH), 126.7 (C),
126.9 (CH), 135.5 (C), 139.9 (C), 162.9 (CO), 199.8 (CO);
Anal. Calcd for C15H16N2O2: C, 70.29; H, 6.29; N, 10.93.
Found: C, 69.91; H, 6.45; N, 11.12; MS m/z 257 (M11)1.
2,4,4,10-Tetramethyl-1,2,3,4,5,10-hexahydroazepino-
[3,4-b]indole-1,5-dione (15). Yield: 3%; mp 105±1068C
(ethyl acetate±petroleum ether); IR (KBr) n 1642 broad
10-Methyl-2-phenylsulfonyl-1,2,3,4,5,10-hexahydroaze-
pino[3,4-b]indole-1,5-dione (12f). According to the pro-
cedure for the synthesis of 12c, compound 12f was
prepared in 90% yield using benzenesulfonyl chloride
(chromatography eluent: petroleum ether±ethyl acetate
8:2); mp 187±1888C (ethyl acetate±petroleum ether); IR
1
(CO) cm21; H NMR (250 MHz, CDCl3) d 1.33 (s, 6H,
(CH3)2), 3.34 (s, 3H, CH3), 3.58±3.78 (m, 2H, CH2), 4.12
(s, 3H, CH3), 7.36±7.47 (m, 3H, HAr), 8.37±8.40 (m, 1H,
HAr); 13C NMR (62.90 MHz, CDCl3) d 23.3 (2CH3), 32.6
(CH3), 37.4 (CH3), 49.5 (C), 58.4 (CH2), 110.2 (CH), 115.4
(C), 123.5 (2CH), 125.5 (CH), 125.9 (C), 133.6 (C), 138.5
(C), 161.6 (CO), 200.7 (CO); Anal. Calcd for C16H18N2O2:
C, 71.09; H, 6.71; N, 10.36. Found: C, 71.43; H, 6.60; N,
10.42; MS m/z 271 (M11)1.
(KBr) n 1672 (CO), 1646 (CO) 1354, 1165 (NSO2) cm21
;
1H NMR (250 MHz, CDCl3) d 3.07±3.11 (m, 2H, CH2),
3.93 (s, 3H, CH3), 4.40±4.44 (m, 2H, CH2), 7.31±7.39 (m,
3H, HAr), 7.56±7.65 (m, 3H, HAr), 8.10 (d, 2H, J8.0 Hz,
HAr), 8.34 (d, 1H, J8.0 Hz, HAr); 13C NMR (62.90 MHz,
CDCl3) d 32.9 (CH3), 42.3 (CH2), 44.5 (CH2), 110.4 (CH),
117.2 (C), 124.0 (CH), 124.4 (CH), 124.8 (C), 126.8 (CH),
128.8 (2CH), 129.1 (2CH), 131.2 (C), 134.3 (CH), 138.7
(C), 139.1 (C), 160.9 (CO), 194.4 (CO); Anal. Calcd for
C19H16N2O4S: C, 61.94; H, 4.38; N, 7.60. Found: C,
61.63; H, 4.27; N, 7.89; MS m/z 369 (M11)1.
10-Methyl-1-oxo-1,2,3,10-tetrahydroazepino[3,4-b]indol-
5-yl tri¯uoromethanesulfonate (16). Yield: 20±30%; mp
202±2038C (ethyl acetate±petroleum ether); IR (KBr) n
3212 (NH), 1640 (CO), 1407 (OSO2), 1209 (OSO2) cm21
;
1H NMR (250 MHz, CDCl3) d 3.65 (dd (d if D2O
exchange), 2H, J6.0, 7.5 Hz, CH2), 4.11 (s, 3H, CH3),
6.08 (t, 1H, J7.5 Hz, CH), 7.24±7.33 (m, 4H, NH1HAr),
7.96±7.99 (m, 1H, HAr); 13C NMR (62.90 MHz, CDCl3) d
32.3 (CH3), 37.2 (CH2), 110.5 (CH), 111.4 (C), 114.7 (CH),
118.4 (q, J320 Hz, CF3), 122.1 (CH), 122.3 (CH), 122.8
(C), 125.9 (CH), 131.4 (C), 138.5 (C), 148.9 (C), 163.4
(CO); Anal. Calcd for C14H11F3N2O4S: C, 46.67; H, 3.08;
N, 7.77. Found: C, 46.98; H, 2.94; N, 7.92; MS m/z 361
(M11)1.
2-Acetyl-10-methyl-1-oxo-1,2,3,10-tetrahydroazepino-
[3,4-b]indol-5-yl acetate (13a). Yield: 13%; gum; IR (®lm)
1
n 1707 (CO), 1652 (CO), 1641 (CO); H NMR (250 MHz,
CDCl3) d 2.29 (s, 3H, CH3), 3.03 (s, 3H, CH3), 4.06 (s, 3H,
CH3), 4.13±4.53 (m, 2H, CH2), 6.05 (t, 1H, J7.3 Hz, CH),
7.18±7.26 (m, 1H, HAr), 7.41±7.43 (m, 2H, HAr), 7.85 (d,
1H, J8.0 Hz, HAr); 13C NMR (62.90 MHz, CDCl3) d 22.1
(CH3), 28.3 (CH3), 33.7 (CH3), 40.3 (CH2), 111.6 (CH),
115.4 (CH), 116.6 (C), 122.9 (CH), 123.2 (CH), 123.8
(C), 127.4 (CH), 131.8 (C), 140.4 (C), 150.0 (C), 163.7
(CO), 169.5 (CO), 173.1 (CO); Anal. Calcd for
C17H16N2O4: C, 65.38; H, 5.16; N, 8.97. Found: C, 65.69;
H, 5.28; N, 8.80; MS m/z 313 (M11)1.
10-Methyl-2-(tri¯uoromethylsulfonyl)-1,2,3,4,5,10-hexa-
hydroazepino[3,4-b]indole-1,5-dione (17). According to
the procedure for the synthesis of 3a, compound 17 was
prepared from 12b in 82% yield; mp 192±1938C (ethyl
acetate±petroleum ether); IR (KBr) n 1684 (CO), 1653
(CO), 1407 (NSO2), 1215 (NSO2) cm21
;
1H NMR
tert-Butyl 5-[(tert-butoxycarbonyl)oxy]-10-methyl-1-oxo-
1,2,3,10-tetrahydroazepino[3,4-b]indole-2-carboxylate
(13b). Yield: 20%; mp 123±1248C (ethyl acetate±petro-
leum ether); IR (KBr) n 1758 (CO), 1704 (CO), 1689
(250 MHz, DMSO-d6) d 3.14 (t, 2H, J5.3 Hz, CH2),
4.08 (s, 3H, CH3), 4.33 (t, 2H, J5.3 Hz, CH2), 7.40 (t,
1H, J8.0 Hz, HAr), 7.54 (t, 1H, J8.0 Hz, HAr), 7.79 (d,
1H, J8.0 Hz, HAr), 8.26 (d, 1H, J8.0 Hz, HAr); 13C NMR
(62.90 MHz, DMSO-d6) d 33.0 (CH3), 44.1 (CH2), 45.2
(CH2), 111.5 (CH), 117.2 (C), 123.1 (CH), 124.0 (C),
124.1 (CH), 124.4 (q, J290 Hz, CF3), 126.9 (CH), 130.1
(C), 139.1 (C), 160.4 (CO), 194.1 (CO); Anal. Calcd for
C14H11F3N2O4S: C, 46.67; H, 3.08; N, 7.77. Found: C,
46.32; H, 3.15; N, 7.89; MS m/z 361 (M11)1.
1
(CO) cm21; H NMR (250 MHz, CDCl3) d 1.41 (s, 9H,
(CH3)3), 1.55 (s, 9H, (CH3)3), 4.03 (s, 3H, CH3), 4.14±
4.24 (m, 2H, CH2), 6.08 (t, 1H, J7.3 Hz, CH), 7.16±7.22
(m, 1H, HAr), 7.35±7.37 (m, 2H, HAr), 7.93 (d, 1H,
J8.5 Hz, HAr); 13C NMR (62.90 MHz, CDCl3) d 27.4
(3CH3), 27.9 (3CH3), 32.5 (CH3), 41.7 (CH2), 83.2 (C),
83.6 (C), 110.2 (CH), 112.6 (CH), 114.7 (C), 121.5 (CH),
122.2 (CH), 122.5 (C), 125.9 (CH), 130.9 (C), 138.8 (C),
149.6 (C), 150.6 (CO), 151.2 (CO), 160.8 (CO); Anal. Calcd
for C23H28N2O4: C, 69.68; H, 7.12; N, 7.07. Found: C,
70.03; H, 7.28; N, 6.89; MS m/z 397 (M11)1.
General procedure for the Stille reaction with 3d
(method A)
To a suspension of freshly prepared tetrakis(triphenylphos-
phine)palladium (15 mg, 0.013 mmol) and LiCl (26 mg,
0.61 mmol) in dry DMF was added a solution of 3d
2,4,10-Trimethyl-1,2,3,4,5,10-hexahydroazepino[3,4-b]-